Search results
Pfizer (NYSE:PFE) Stock Price Up 1.8% on Earnings Beat
ETF DAILY NEWS· 5 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) shares rose 1.8% during mid-day trading on Thursday after the company announced better than expected quarterly earnings. The company ...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 3 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 2 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via AOL· 3 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 4 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 3 days agoPfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks· 3 days agoPfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
NHS to provide Pfizer’s Voxelotor to treat sickle cell disease
Pharmaceutical Technology via Yahoo Finance· 21 hours agoThe UK's National Health Service (NHS) has announced plans to offer Pfizer's Voxelotor (Oxbryta), a...